Substance use disorder treatment can involve anything from outpatient counseling to residential care, medication, and hospital services, so costs can vary substantially. At the same time, clinical trials continue testing new ways to prevent and treat addiction. Understanding both sides of the system can help patients and families make sense of what treatment may involve, how it is funded, and how research participation works.
Why Substance Use Treatment Costs Vary
There is no single standard price for substance use disorder treatment. Costs depend on the type of care, how frequently services are provided, how long treatment lasts, the staffing required, and whether the patient needs medication, medical monitoring, or residential accommodation.
Economic research examining more than 100 treatment programs found substantial cost differences among methadone maintenance, outpatient care, residential programs, drug courts, and therapeutic communities (source). Those differences reflect the fact that each setting requires a different mix of clinicians, facilities, medications, supervision, and support services.
Older studies can help demonstrate how widely costs vary, but their dollar amounts should not be treated as current prices. Many frequently cited treatment-cost estimates were calculated using data from the early 2000s or earlier. Someone looking for care today should instead ask individual programs and insurers for current estimates.
Who Pays for Treatment?
Patients do not necessarily pay the full cost of substance use treatment themselves. Depending on eligibility and the treatment setting, funding may come from private insurance, Medicaid, Medicare, state or local programs, federal grants, or nonprofit organizations.
Federal funding remains an important part of the treatment system. In 2026, the Substance Abuse and Mental Health Services Administration announced new funding for programs intended to expand substance use prevention, treatment, and recovery services, including support for rural communities, Tribal populations, families, and people affected by drug use (source).
For an individual seeking treatment, however, the most useful questions are practical ones: whether a provider accepts the person's insurance, what deductible or coinsurance applies, whether medications are included, and whether financial assistance or sliding-scale fees are available.
Untreated Substance Use Also Carries Major Costs
The expense of treatment is only part of the financial picture. Substance use disorders can also generate significant hospital costs when people require emergency or inpatient care.
An economic analysis using 2017 hospital data estimated that substance use disorders accounted for about $13.2 billion in attributable U.S. emergency-department and inpatient medical costs that year. Alcohol-related disorders represented the largest share, at approximately $7.6 billion (source).
The researchers concluded that investments in effective prevention and treatment could potentially be offset in part by reductions in expensive hospital care. That does not mean every treatment program automatically saves money, but it illustrates why treatment access is both a health issue and an economic one.
What Happens Before Someone Joins a Clinical Trial?
Clinical trials are organized research studies designed to answer specific health questions. In addiction research, they may examine medications, behavioral therapies, prevention approaches, combinations of treatments, or ways to improve recovery.
Participation begins with information and screening. Research staff explain the study, answer questions, and provide an informed-consent document describing what participation involves, including potential risks and benefits. The person is then screened to determine whether they meet the study's eligibility requirements (source).
Signing a consent form does not mean giving up personal control. Participants can ask questions throughout the study and may withdraw from a clinical trial at any time.
Randomization, Control Groups, and Study Protocols
Some clinical trials randomly assign participants to different groups. One group may receive the treatment being studied, while another receives standard care, a different treatment, or in some studies a placebo. Random assignment helps researchers compare outcomes while reducing bias (source).
Trials follow a detailed protocol that specifies who can participate, what treatments or procedures will be used, what information will be collected, how long the study will last, and how participant safety will be monitored. Researchers may also use blinding, meaning participants, researchers, or both may not initially know which treatment was assigned.
Enrollment therefore does not guarantee that someone will receive the experimental treatment. The exact design should be explained during informed consent.
How Clinical Trial Phases Work
Drug and treatment trials often progress through several phases. Phase I studies generally focus on safety and dosage in a relatively small group. Phase II studies involve more participants and examine whether the treatment appears effective while continuing to monitor safety. Phase III trials test the treatment in still larger groups and may compare it with existing treatment or a placebo. Phase IV research occurs after approval and continues evaluating real-world safety and effectiveness (source).
Not every behavioral or addiction study follows the same phase structure, but every legitimate clinical trial should have clearly defined goals, eligibility criteria, procedures, and safeguards.
Understanding Costs and Research Together
Substance use treatment costs vary because treatment itself varies. Outpatient counseling, residential programs, medication-based care, and hospital services all require different resources, while insurance and public funding determine how much of those costs ultimately reach the patient.
Clinical trials operate differently from routine treatment. They are structured research programs with consent procedures, eligibility rules, protocols, comparison groups, and safety monitoring. Understanding that distinction can help patients and families evaluate both established treatment options and opportunities to participate in research with clearer expectations.